Literature DB >> 16786177

Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema.

Mehmet Bahadir1, Aylin Ertan, Ozgür Mertoğlu.   

Abstract

PURPOSE: To evaluate whether internal limiting membrane (ILM) peeling during vitrectomy affects vision outcome in patients with diabetic macular edema. MATERIAL AND
METHOD: Fifty-eight eyes of 49 patients were included in the study. Patients with persistent diffuse clinically significant macular edema were divided into two groups according to the surgical method used. Group I subjects (15 patients; mean age 56.60+/-8.50 years; 17 eyes total) underwent vitrectomy with ILM peeling. Group II subjects (34 patients; mean age 57.52+/-11.54 years; 41 eyes total) underwent vitrectomy without ILM peeling. The data recorded for each case were type and duration of diabetes, insulin treatment (yes/no), presence of arterial hypertension, stage of diabetic retinopathy, lens status, history of macular laser treatment, and detection of posterior vitreous detachment during surgery. Visual acuity was measured preoperatively and 1 year postoperatively in decimal notation, and values were converted to logarithm of minimal-angle-of-resolution (logMAR) scores. Mean pre- and postoperative visual acuity were compared within each group, and the mean change in visual acuity in Group I was compared to that in Group II.
RESULTS: There were no significant differences between the groups with respect to age; sex distribution; diabetes type; duration of diabetes; numbers of patients on insulin treatment; frequencies of hypertension, proliferative diabetic retinopathy, previous macular laser treatment; or frequency of intraoperatively confirmed posterior vitreous detachment (chi-square, P>0.05 for all). Comparison of pre- and post-operative visual acuity revealed significant improvement in both Group I (1.15+/-0.307 vs. 0.764+/-0.355 logMAR, respectively; Wilcoxon rank test, P<0.01) and Group II (1.22+/-0.516 vs. 0.829+/-0.436 logMAR, respectively; Wilcoxon rank test, P<0.001). The change in visual acuity for Group I was not significantly different from that observed in Group II (0.391+/-0.335 vs. 0.393+/-0.273 logMAR, respectively; Mann-Whitney U test, P>0.05).
CONCLUSION: The visual acuity outcomes in the study indicate that vitrectomy without ILM peeling is just as effective as vitrectomy with ILM peeling in the treatment of diabetic macular edema. Both techniques led to significant and similar degrees of improvement in visual acuity.

Entities:  

Mesh:

Year:  2006        PMID: 16786177     DOI: 10.1007/s10792-006-0008-4

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  28 in total

1.  Vitrectomy for diabetic macular edema with and without internal limiting membrane removal.

Authors:  Teiko Yamamoto; Koichiro Hitani; Yukihiro Sato; Hidetoshi Yamashita; Shinobu Takeuchi
Journal:  Ophthalmologica       Date:  2005 Jul-Aug       Impact factor: 3.250

2.  Posterior precortical vitreous pocket.

Authors:  S Kishi; K Shimizu
Journal:  Arch Ophthalmol       Date:  1990-07

3.  Vitreous cortex remnants at the fovea after spontaneous vitreous detachment.

Authors:  S Kishi; C Demaria; K Shimizu
Journal:  Int Ophthalmol       Date:  1986-12       Impact factor: 2.031

4.  Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.

Authors:  A Gandorfer; E M Messmer; M W Ulbig; A Kampik
Journal:  Retina       Date:  2000       Impact factor: 4.256

5.  Macular hole surgery with internal-limiting membrane peeling and intravitreous air.

Authors:  D W Park; J O Sipperley; S R Sneed; P U Dugel; J Jacobsen
Journal:  Ophthalmology       Date:  1999-07       Impact factor: 12.079

6.  Role of the vitreous in cystoid macular edema.

Authors:  C L Schepens; M P Avila; A E Jalkh; C L Trempe
Journal:  Surv Ophthalmol       Date:  1984-05       Impact factor: 6.048

7.  Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients.

Authors:  Yumi Kamura; Yukihiro Sato; Takako Isomae; Hiroyuki Shimada
Journal:  Jpn J Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 2.447

8.  Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.

Authors:  A W Stitt; J E Moore; J A Sharkey; G Murphy; D A Simpson; R Bucala; H Vlassara; D B Archer
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-12       Impact factor: 4.799

9.  Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide.

Authors:  Koh-Hei Sonoda; Taiji Sakamoto; Hiroshi Enaida; Miho Miyazaki; Yoshihiro Noda; Takao Nakamura; Akifumi Ueno; Mitsunobu Yokoyama; Toshiaki Kubota; Tatsuro Ishibashi
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

10.  Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane.

Authors:  J W Harbour; W E Smiddy; H W Flynn; P E Rubsamen
Journal:  Am J Ophthalmol       Date:  1996-04       Impact factor: 5.258

View more
  14 in total

1.  Efficacy and safety of vitrectomy with internal limiting membrane peeling for diabetic macular edema: a Meta-analysis.

Authors:  Xin-Ying Hu; Huan Liu; Li-Na Wang; Yu-Zhi Ding; Jie Luan
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

2.  Prediction of postoperative visual outcome after pars plana vitrectomy based on preoperative multifocal electroretinography in eyes with diabetic macular edema.

Authors:  Yong Min Kim; Soo Young Lee; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-06       Impact factor: 3.117

Review 3.  ILM peeling in nontractional diabetic macular edema: review and metanalysis.

Authors:  M Rinaldi; R dell'Omo; F Morescalchi; F Semeraro; E Gambicorti; F Cacciatore; F Chiosi; C Costagliola
Journal:  Int Ophthalmol       Date:  2017-10-31       Impact factor: 2.031

4.  Dilute triamcinolone-assisted peeling of the internal limiting membrane in cases of diffuse diabetic macular oedema.

Authors:  Remzi Avci; Berrin Avci; Berkant Kaderli
Journal:  Int Ophthalmol       Date:  2006-12-01       Impact factor: 2.031

5.  Effect of vitrectomy with silicone oil tamponade and internal limiting membrane peeling on eyes with proliferative diabetic retinopathy.

Authors:  Sung Yeon Jun; Daniel Duck-Jin Hwang
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

6.  Surgical outcomes of vitrectomy for intractable diabetic macular edema.

Authors:  Ryo Mukai; Hidetaka Matsumoto; Hideo Akiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-20       Impact factor: 3.117

Review 7.  Diabetic macular edema: New promising therapies.

Authors:  Hanan N Al Shamsi; Jluwi S Masaud; Nicola G Ghazi
Journal:  World J Diabetes       Date:  2013-12-15

8.  Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial.

Authors:  Hans Hoerauf; Anne Brüggemann; Manuela Muecke; Julia Lüke; Maya Müller; Einar Stefánsson; Hans-Peter Hammes; Claudia Weiss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-18       Impact factor: 3.117

9.  Combined vitrectomy and intravitreal injection versus combined laser and injection for treatment of intractable diffuse diabetic macular edema.

Authors:  Ahmed M Saeed
Journal:  Clin Ophthalmol       Date:  2013-02-14

10.  Evaluation of the efficacy of vitrectomy for persistent diabetic macular edema and associated factors predicting outcome.

Authors:  Su Jeong Song; Joon Hong Sohn; Kyu Hyung Park
Journal:  Korean J Ophthalmol       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.